Pharma firm’s profits quadruple to €341m

Pre-tax profits at the main Irish subsidiary of US-owned pharmaceutical firm, Forest Laboratories last year increased more than four-fold to $426.49m (€341m).

This followed revenues at the Dublin-based firm increasing by 16% from $2.13bn to $2.48bn in the 12 months to the end of March.

The $2.1bn in revenues generated by the Dublin unit accounted for 69% of the company’s global revenues of $3.6bn in fiscal 2014.